Kevin Wirges - 08 Jun 2023 Form 4 Insider Report for CareMax, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Jun 2023, 20:10:05 UTC
Prior SEC filing
16 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Meredith Longsworth, Esq., as Attorney-in-Fact for Kevin Wirges

Key filing fact

Kevin Wirges filed Form 4 for CareMax, Inc. on 12 Jun 2023.

Key facts

  • This page summarizes Kevin Wirges's Form 4 filing for CareMax, Inc..
  • 5 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 12 Jun 2023, 20:10.

Change

  • Previous filing in this sequence was filed on 16 May 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CMAX transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+4,433
Change %
+2.8%
Price
Shares after
165,579
Date
08 Jun 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CMAX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-4,433
Change %
-50%
Price
$0.000000
Shares after
4,433
Date
08 Jun 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
4,433
Exercise price
$0.000000
Footnotes
F2
CMAX transaction Derivative

Performance Stock Units

Award

Transaction value
$0
Shares
+33,250
Change %
Price
$0.000000
Shares after
33,250
Date
08 Jun 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
33,250
Exercise price
$0.000000
Footnotes
F3
CMAX transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+66,500
Change %
Price
$0.000000
Shares after
66,500
Date
08 Jun 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
66,500
Exercise price
$0.000000
Footnotes
F4
CMAX transaction Derivative

Stock Option (Employee Right to Buy)

Award

Transaction value
$0
Shares
+66,500
Change %
Price
$0.000000
Shares after
66,500
Date
08 Jun 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
66,500
Exercise price
$3.72
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

On June 8, 2023, the reporting person received shares of the issuer's Class A common Stock ("Common Stock") in settlement of restricted stock units, which vested on June 8, 2023.

Footnote F2

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock in accordance with the issuer's 2021-Long-Term Incentive Plan (the "Plan") On October 29, 2021, the reporting person was granted 13,300 RSUs, vesting in three equal installments on October 29, 2022, June 8, 2023, and June 8, 2024.

Footnote F3

Each performance stock unit ("PSU") represents a contingent right to receive one share of Common Stock in accordance with the Plan. The PSUs vest based on the volume weighted average price (the "VWAP") of the Common Stock during the thirty trading days prior to June 8, 2025 (the "Measurement Period"). The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on the VWAP of the Common Stock during the Measurement Period.

Footnote F4

Each RSU represents a contingent right to receive one share of Common Stock in accordance with the Plan. The RSUs will vest in three equal installments on June 8, 2024, June 8, 2025 and June 8, 2026.

Footnote F5

Each stock option represents a contingent right to receive, upon the exercise of a vested stock option, one share of Common Stock in accordance with the Plan. The stock options will vest in three equal installments on June 8, 2024, June 8, 2025 and June 8, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .